FLEXJAK ER 11MG

Flexjak ER 11mg Tablet is indicated for the management of moderate to severe cases of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. This medication works by alleviating pain, tenderness, and inflammation in affected joints, thereby reducing swelling and discomfort. Additionally, it serves to slow down the deterioration of bone and joint integrity. The tablet may be prescribed alone or alongside other therapeutic agents. Administration can occur with or without food, but consistency in timing is recommended, taking it at the same hour each day to maintain even levels in the bloodstream. The appropriate dosage will be contingent upon your specific health condition and any concurrent medications you may be using. Adherence to your healthcare provider’s instructions is critical; do not discontinue use unless advised, as doing so may exacerbate your condition. Before initiating treatment, blood tests may be required, and it is essential to avoid this medication if you have an active infection. Discuss your medical history with your healthcare provider, particularly if you have a history of tuberculosis, shingles, liver or kidney issues, hepatitis B or C, or a history of blood clots. This medication has the potential to increase the risk of infections or exacerbate existing ones, making it important to steer clear of individuals with contagious illnesses. Flexjak ER 11mg Tablet is unsuitable for individuals under 18 years of age, and its use during pregnancy or breastfeeding should be approached with caution, requiring your doctor to evaluate the potential risks against the anticipated benefits. Regular monitoring by your healthcare provider may also be necessary during treatment.